Cargando…
Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry
Achieving target serum uric acid (SUA) levels is important in gout management. Guidelines recommend lowering SUA levels to < 6 mg/dL; however, many patients fail to reach this target, even with uric acid-lowering therapy (ULT). This study investigated clinical characteristics of target SUA achiev...
Autores principales: | Do, Hyunsue, Choi, Hyo Jin, Choi, Byoongyong, Son, Chang-Nam, Kim, Sang-Hyon, Choi, Se Rim, Kim, Ji Hyoun, Kim, Min Jung, Shin, Kichul, Kim, Hyun-Ok, Song, Ran, Lee, Sung Won, Ahn, Joong Kyong, Lee, Seung-Geun, Lee, Chang Hoon, Son, Kyeong Min, Moon, Ki Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665459/ https://www.ncbi.nlm.nih.gov/pubmed/37993515 http://dx.doi.org/10.1038/s41598-023-47790-6 |
Ejemplares similares
-
Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4–5 chronic kidney disease not yet on dialysis
por: Kim, Sang-Hyon, et al.
Publicado: (2020) -
Effect of fenofibrate on uric acid level in patients with gout
por: Jung, Ju-Yang, et al.
Publicado: (2018) -
Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence
por: Chung, Min Kyung, et al.
Publicado: (2021) -
Cardiovascular Risks in Korean Patients with Gout: Analysis Using a National Health Insurance Service Database
por: Moon, Ki Won, et al.
Publicado: (2022) -
Chronic urate nephropathy with a disproportionated elevation in serum uric acid
por: Lee, Sik, et al.
Publicado: (2010)